EHP
LIVE

Serial Number

79266404

Owner

Dr. med. Gerhard Siebenhüner

Attorney

Margaret C. McHugh

Filing Date

May 15, 2019

Add to watchlist:

No watchlists yet
View on USPTO

EHP Trademark

Serial Number: 79266404 • Registration: 6258611

EHP is a trademark filed by Dr. med. Gerhard Siebenhüner on May 15, 2019. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Dr. med. Gerhard Siebenhüner

Burgstr. 8

Entity Type: 01

Trademark Details

Filing Date

May 15, 2019

Registration Date

February 2, 2021

Published for Opposition

November 17, 2020

Goods & Services

Advisory or additive services relating to therapy for the treatment of tumors of the human or animal body, namely development of medical imaging methods, laboratory analyses, chemosensitivity testing, gene analyses for medical research or diagnostic purposes; advisory or additive services relating to therapy for the purification of blood in surgical or theoretic procedures, namely imaging methods, laboratory analyses, medical laboratory chemosensitivity testing, gene analyses for medical research purposes, therapy monitoring for medical research purposes, therapy setting for medical research purposes, therapy adjustment for medical research purposes; services provided by a supplier of medical apparatus and instruments, namely technical advice relating to the operation of medical equipment and instruments adapted to the customer's specific applications, functional analysis, device adjustment in the nature of calibration, quality control, calibration of medical equipment and instruments; development and research services relating to new products for third parties in the field of hemoperfusion therapy or hyperthermia, therapy based on hyperthermia, oxygen supply and adsorption of molecules from blood; biological research; research in the field of chemistry; research in the field of hemoperfusion therapy or hyperthermia, therapy based on hyperthermia, oxygen supply and adsorption of molecules from blood

Medical apparatus for treating tumors of the human or animal body; apparatus for purifying the blood during surgical or therapeutic procedures; medical apparatus and instruments, namely, blood, blood purification, toxin, pesticide, parasite, drug, poison, heavy metal, bacteria and virus, immunopathogenic agent, bilirubin, and beta 2 microglobulin filters; medical apparatus and instruments, namely, drug delivery, blood, fluid, peristatic, membrane, and centrifugal pumps; medical apparatus and instruments, namely, adsorbers for blood purification and removal of toxins, pesticides, parasites, drugs, poison, heavy metal, bacteria, viruses, immunopathogenic agent, bilirubin, beta 2 microglobulin from the blood; medical apparatus and instruments, namely, heat exchangers, oxygenators, devices for ozone production, ozone devices for treatment of blood, ozone devices for the killing and removal of bacteria, viruses, and parasites, tube systems comprised of tubes for passing blood and fluids, hemoperfusion devices, blood purification devices, devices for inducing hyperthermia, devices for thermotherapy, blood perfusion devices, perfusion devices for the treatment of blood, perfusion cutlery for surgery; surgical apparatus and instruments; diagnostic and therapeutic equipment in the pharmaceutical, medical and veterinary fields, namely, equipment for blood gas analysis, devices for measuring blood coagulation, devices for measuring oxygen saturation, devices for measuring body temperature, hemoperfusion devices for the treatment of blood, clinical laboratory analyzers for blood and blood component analysis, chemistry analyzers for blood and blood component analysis, automated sample handling equipment for testing purposes, immunohematology analyzer for blood and blood component analysis, apparatus for blood screening, blood typing, detection of assays associated with blood screening and blood typing used in the transfusion medicine market; medical instruments for the extracorporeal destruction of cancer cells, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy; medical instruments for the extracorporeal purification of the blood and supply of natural or chemical substances to the body, namely, filter, pumps, adsorbers, infusion equipment for drug delivery, pain therapy, blood purification, blood perfusion; medical instruments, namely, patient cradle equipment suitable for use in hyperthermia, thermotherapy or thermometry treatments, namely, control devices, control systems, controller such as temperature controller; medical apparatus, equipment and instruments for chemotherapy and electrochemical tumor therapy; medical apparatus, namely, hyperthermia systems, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy

Medical services in the field of oncology; medical services for the treatment of diseases of the human or animal body; provision of heat therapy for treating tumors in human or animals, hyperthermia, hemoperfusion therapy; blood purification services for surgical or therapeutic procedures

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 2, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 6, 2021 FICS
FINAL DISPOSITION PROCESSED
May 6, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 2, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 2, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Dec 12, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2020 OPNS
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 17, 2020 PUBO
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 28, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 28, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 9, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 9, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 9, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 9, 2020 CNEA
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Aug 6, 2020 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Aug 6, 2020 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Aug 6, 2020 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 7, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 14, 2020 GNFN
FINAL REFUSAL E-MAILED
Apr 14, 2020 GNFR
FINAL REFUSAL WRITTEN
Apr 14, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2020 TROA
REFUSAL PROCESSED BY IB
Oct 12, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 26, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 26, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Sep 14, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 13, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 12, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 29, 2019 REPR